CELEX: 32020M9876
Language: en
Date: 2020-09-10 00:00:00
Title: Commission Decision of 10/09/2020 declaring a concentration to be compatible with the common market (Case No COMP/M.9876 - TA ASSOCIATES / FRANCISCO PARTNERS / EDIFECS) according to Council Regulation (EC) No 139/2004 (Only the English text is authentic)

EUROPEAN COMMISSION
                                                                Brussels, 10.09.2020
                                                                C(2020) 6307 final
                                                                                PUBLIC VERSION
                                                                To the notifying parties
Subject:        Case M.9876 – TA ASSOCIATES / FRANCSICO* PARTNERS / EDIFECS
                Commission decision pursuant to Article 6(1)(b) of Council Regulation
                                       1
                (EC) No 139/2004 and Article 57 of the Agreement on the European
                                    2
                Economic Area
Dear Sir or Madam,
1.      On 13 August 2020, the European Commission received notification of a proposed
        concentration pursuant to Article 4 of the Merger Regulation by which funds managed
        by TA Associates Management L.P. (“TA Associates”, United States), and funds
        managed by Francisco Partners Management LP (“Francisco Partners”, United
        States), acquire within the meaning of Article 3(1)(b) and 3(4) of the Merger
        Regulation joint control over the whole of the undertaking Edifecs, Inc. (“Edifecs”,
        United States) by way of purchase of shares.3
2.      The business activities of the undertakings concerned are:
             for TA Associates: private equity firm, active in investing in five core sectors,
              namely technology, financial services, healthcare, consumer and business services
              industries in Europe, North America and Asia.
             for Francsisco* Partners: private equity firm exclusively focused on investment in
              technology and technology-enabled businesses.
             for Edifecs: healthcare technology company active in the provision of
              infrastructure solutions which aim to improve operational performance by
              streamlining the exchange of information between hospitals and other healthcare
              organizations, while enabling compliance with industry regulations.
*       Should read: “Francisco”
1       OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’). With effect from 1 December 2009, the Treaty on
        the Functioning of the European Union (‘TFEU’) has introduced certain changes, such as the
        replacement of ‘Community’ by ‘Union’ and ‘common market’ by ‘internal market’. The terminology
        of the TFEU will be used throughout this decision.
2       OJ L 1, 3.1.1994, p. 3 (the ‘EEA Agreement’).
3       Publication in the Official Journal of the European Union No C 278, 24.08.2020, p. 4.
Commission européenne, DG COMP MERGER REGISTRY, 1049 Bruxelles, BELGIQUE
Europese Commissie, DG COMP MERGER REGISTRY, 1049 Brussel, BELGIË
Tel: +32 229-91111. Fax: +32 229-64301. E-mail: COMP-MERGER-REGISTRY@ec.europa.eu.
 ---pagebreak--- 3. After examination of the notification, the European Commission has concluded that
   the notified operation falls within the scope of the Merger Regulation and of
   paragraph 5(a) of the Commission Notice on a simplified procedure for treatment of
   certain concentrations under Council Regulation (EC) No 139/2004.4
4. For the reasons set out in the Notice on a simplified procedure, the European
   Commission has decided not to oppose the notified operation and to declare it
   compatible with the internal market and with the EEA Agreement. This decision is
   adopted in application of Article 6(1)(b) of the Merger Regulation and Article 57 of
   the EEA Agreement.
                                                  For the Commission
                                                  (Signed)
                                                  Olivier GUERSENT
                                                  Director-General
4  OJ C 366, 14.12.2013, p. 5.
                                              2